During the holidays, people with breathing problems want to enjoy quality time with loved ones. Spiro PD helps make that possible by allowing patients to easily and accurately monitor their lung health.
Allentown, Pennsylvania (PRWEB) December 18, 2012
Family and friends of people with chronic breathing problems, such as asthma, COPD, bronchitis, emphysema, cystic fibrosis, and a lung transplant, are choosing the Spiro PD Personal Spirometer as the perfect holiday gift to track lung health to help prevent possible complications from colds and the flu.
Spiro PD is the world’s first truly personal spirometer. It empowers people with respiratory conditions to easily and accurately monitor their breathing any time and anywhere: at home, work, school, play, or while traveling.
Spiro PD helps patients adhere to their medication regimen by permitting them to manage their medications, view medication history, and set alarms reminding them when to take medicine, test lung function, and do breathing exercises.
By helping patients monitor and prevent breathing problems, Spiro PD can reduce expensive emergency room visits and hospital stays. It also helps prevent readmissions, so hospitals can avoid costly Medicare penalties.
Spiro PD also offers an innovative telemedicine feature that lets patients easily upload and send their lung function data to their doctor to determine the person’s lung health and need for any treatment changes. The telemedicine feature is particularly valuable for people who are physically challenged or live a long distance from their doctors.
Says Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, the maker of Spiro PD, “During the holidays, people with breathing problems want to enjoy quality time with loved ones. Spiro PD helps make that possible by allowing patients to easily and accurately monitor their lung health.”
For more information about all the advantages that Spiro PD offers people with respiratory conditions, please visit http://www.SpiroPD.com.
About Spiro PD
“Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases – COPD, asthma, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere.
Spiro PD tracks lung function trends to help patients anticipate and prevent respiratory disease exacerbations, which helps reduce expensive emergency room visits and hospital stays. According to a study conducted at Johns Hopkins University, home spirometry detected decreased lung function 16 days before patients felt symptoms and sought medical care.(1)
Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.
Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.
Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Many insurance companies cover the cost of Spiro PD.
Spiro PD meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. Spiro PD is also certified with the CE mark for the European Union (EU).
For more information, visit http://www.SpiroPD.com.
About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.
1. West NE, Boyle MP, Mogayzel PJ, Riekert KA, Lechtzin N. The ability of home spirometry and symptom monitoring to predict exacerbations in cystic fibrosis. Pediatric Pulmonology 2009; Vol. 34, S32 “Poster Session Abstract” poster 376.